Hubungan Kadar Lipoprotein dengan Kejadian Stroke dan Tumor Otak
DAFTAR PUSTAKA
Ahmadraji, T., Killard, A. 2013. The Evolution of Selective Analyses of HDL
and LDL Cholestrol in Clinical and Point of Care Testing. Analytical
Method; 5(15): 3612-25
Armstrong, T.S., Sloan, J.B., Brem, S.S., Chang, S. 2010. Brain Tumor
Basics. In : Brain Tumor Primer. Nineth Edition. Pp. 9-12. Williams and
Wilkens. Illinois.
Birtcher, K.K., Ballantyne, C.M. 2004. Measurement of Cholestrol: A Patient
Perspective. Circulation; 110: 296-297
Bendel, A., Beaty, O., Bottom, K., Bunin, G., Wrensch, M. 2006. Central
Nervous System Cancer. In : Bleyer, A., Leary, M., Barr, R., Ries,
L.A.G. editors. Cancer Epidemiology in Older Adoslescents and Young
Adults 15 to 29 Years of Age. National Cancer Institute. Bethesda.
Bondy, M.L., Scheurer, M.E., Malmer, B., Sloan, J.S.B., Davis, F.G.,
Ilyasova, D., dkk. 2008. Brain Tumor Epidemiology : Consensus from
the Brain Tumor Epidemiology Consortium. Cancer ; 113(7): 1953-1968
Brouwser, H.B, Goldstein, J.N. 2012 Therapeutic Strategies in Acute
Intracerebral Hemorrhage. Neurotherapeutics; 9: 87-98
Brunzell, J.D., Davidson, M., Furberg, C.D., Goldberg, R.B., Howard, B.V.,
Stein, J.H., dkk. 2008. Lipoprotein Management in Patients With
Cardiometabolic Risk. Diabetes Care; 31(4): 811-22
Caplan, L.R. 2000. Caplan’s Stroke : A Clinical Approach. 3rd
Butterworth-Heinemann. Boston
ed.
Cobbold, C.A., Sherratt, J.A., Maxwell, R.J. 2002. Lipoprotein Oxidation and
its Significance for Aterosclerosis : a Mathematical Approach. Bulletin of
Mathematical Biology; 64: 65-95
Crook, M.A. 2012. Plasma Lipids and Lipoproteins. In: Arnold, H., editors.
Clinical Biochemistry and Metabolic Medicine. Hodder Education. Pp.
200-207
Curb, J.D., Abbott, R.D., Rodriguez, B.L., dkk. 2004. High Density
Lipoprotein Cholestrol and the Risk of Stroke in Elderly Men. Am J
Epidemiol; 160(2): 150-7
Universitas Sumatera Utara
Dabrowa, A.B., Hannam, S., Rysz, J., Banach, M. 2011. MalignancyAssociated Dyslipidemia. The Open Cardiovascular Medicine Journal;
5: 35-40
Flaherty, M., Woo, D., Brodrick, J. 2010. The Epidemiology of Intracerebral
Hemorrhage. In: Carhuapoma, J.R, Mayer, S.A, Hanley, D.F., editors.
Intracerebral Hemorrhage. Cambridge University Press
Garcia, S.G., Concepcion, O.S., Carriera, R.F., Sainz, C.M., Maza, J.,
Monteagudo, A.G.Q., dkk. 2008. Association between Blood Lipids and
Types of Stroke. MEDICC Review; 10(2): 27-32
Gatchev, O., Rastam, L., Lindberg, G., Gullberg, B., Tornberg, S., Eklund,
G.A. 1994. Tumours of the Central Nervous System and Concentration
of Total Serum Cholestrol and β-Lipoprotein in Men and Women. Br J
Cancer; 70: 668-71
Growder, D., Riley, C., Morrison, E.Y., Gordon, L. 2011. The Role of HighDensity Lipoproteins in Reducing the Risk of Vascular Disease,
Neurodegenerative Disorders, and Cancer. Cholestrol; 2011 :1-9
Hasan, H.R., Al-Samaraae, S.S. 2009. Study of Lipoproteins in Patients with
Brain Tumor. Basic Sciences; 25(2): 9-18
Hu, J., Vecchia, L., Groh, M., Negri, E., Morrison, H., Mery, L. 2011. Dietary
Cholestrol Intake and Cancer. Annals of Oncloogy; 23(2): 491-500
Hill, C.I., Nixon, C.S., Ruehmeier, J.L., Wolf, L.M. 2002. Brain Tumours. Phys
Ther;82: 496-502
Jonas, A. 2002. Lipoprotein Structure. In : Vance, D.E., Vance, J.E., editors.
Lipoprotein and Membranes. Elsvier Science B.V. Pp.483-504
Konsensus Pengelolaan dan Pencegahan Diabetes Melitus Tipe 2 di
Indonesia. Jakarta. 2006.
Langsted, A., Freiberg, J.J., Nordestgaard, B.G. 2008. Influence of Normal
Fod Intake on Lipids, Lipoproteins, Apolipoproteins, and Cardiovascular
Risk Prediction. Circulation 118: 2047-56
Lloyd-Jones, D., Adams, R., Carnethon, M., Simone, G., Ferguson, B.,
Flegal, K. 2009. Heart Disease and Stroke Statistics-2009 Update : A
Report From the American Heart Association Statistics Committee and
Stroke Statistics Subcommittee. Circulation 119:e21-e181.
Universitas Sumatera Utara
Louis, D.N., Ohgaki, H., Wiestler, O.D., dkk. 2007. The 2007 WHO
Classification of Tumours of The Central Nervous System. Acta
Neuropathol; 114: 97-109
Machfoed, M.H. 2003. The Latest Clinical Epidemiological Data of Ischemic
and Hemorrhagic Stroke Patients in Surabaya and Surroundings. A
Hospital Based Study. Folia Medica Indonesia. 39:242-50
Mahmood, A., Sharif, M.A., Khan, M.N., Ali, U.Z. 2010. Comparison of Serum
Lipid Profile in Ischaemic and Haemorrhagic Stroke. Journal of the
College of Physicians and Surgeons Pakistan; 20(5): 317-20
McKinney, P.A. 2004. Brain Tumors: Incidence, Survival, and Aetiology. J
Neurol Neurosurg Psychiatry; 75: 12-17
Misbach, J. 2007. Pandangan Umum Mengenai Stroke. Dalam : Rasyid, A.
dan Soertidewi, L. (eds). Unit Stroke. Manajemen Stroke Secara
Komprehensif. Hal 1-9. Balai Penerbit FK Universitas Indonesia,
Jakarta.
Misbach, J. 2011. Stroke : Aspek Diagnostik, Patofisiologi, Manajemen.
Badan Penerbit FKUI.
Nigam, P.K. 2011. Serum Lipid Profile: Fasting or Non-fasting?. Ind J Clin
Biochem. 26(1) : 96-97
Oemiati, R., Rahajeng, E., Kristanto, A.Y. 2011. Prevalensi Tumor dan
Beberapa Faktor yang Mempengaruhinya di Indonesia. Buletin
Penelitian Kesehatan; 39: 190-204
Rader, D.J., Hobbs, H.H. 2010. Disorder of Lipoprotein Metabolism. In :
Jameson, J.L., editors. Endocrrinology. McGraw Hill Professional
Publishing. Pp 333-353
Rahmathulla, G., Toms, S.A., Weil, R.J. 2012. The Molecular Biology of Brain
Metastasis. Journal of Oncology; 2012 :1-13
Rodriguez, D., Rubiera, M., Ribo, M., dkk. 2011. Serum Low Density
Lipoprotein Cholestrol Level Predicts Hematoma Growth and Clinical
Outcome After Intracerebral Hemorrhage. Stroke; 42: 2447-52
Sacco, R.L., Kasner, S.E., Broderick, J.P., Caplan, L.R.,Culebras, A., Elkind,
M.S.V.,et al. 2013. An Update Defenition of Stroke for the 21st Century:
a Statement for Healthcare Professionals from the American Heart
Association/American Stroke Association. Stroke; 44:2064-2089
Universitas Sumatera Utara
Sjahrir, H. 2003. Stroke Iskemik. Yandira Agung Medan.
Soyama, Y., Miura, K., Morikawa, Y., Nishijo, M., Nakanishi, Y., Naruse, Y.,
dkk. 2003. High Density Lipoprotein Cholestrol and Risk of Stroke in
Japanese Men and Women : The Oyabe Study; 34: 863-8
Sredhar, K., Srikant, B., Joshi, L., Usha, G. 2010. Lipid Profile in NonDiabetic Stroke-A study of 100 Cases. JAPI; 58: 547-51
Truelsen, T., Piechonski-Jozwiak, B., Bonita, R. 2006. Stroke Incidence and
Prevalence in Europe: a review of available data. European Journal of
Neurology. 13(6):581-589
Wilhelm, I., Molnar, J., Fazakas, C., Hasko, J., Krizbai, I.A. 2013. Role of the
Blood-Brain Barrier in the Formation of Brain Metastases. Int. J. Mol.
Sci; 14: 1383-1411
Woodward, M., Barzi, F., Feigin, V., Gu, D., Huxley, R., Nakamura, K., et al.
2007. Associations between High-Density Lipoprotein Cholestrol and
both Stroke and Coronary Heart Disease in the Asia Pacific Region.
European Heart Journal; 28: 2653-2660
Universitas Sumatera Utara
Ahmadraji, T., Killard, A. 2013. The Evolution of Selective Analyses of HDL
and LDL Cholestrol in Clinical and Point of Care Testing. Analytical
Method; 5(15): 3612-25
Armstrong, T.S., Sloan, J.B., Brem, S.S., Chang, S. 2010. Brain Tumor
Basics. In : Brain Tumor Primer. Nineth Edition. Pp. 9-12. Williams and
Wilkens. Illinois.
Birtcher, K.K., Ballantyne, C.M. 2004. Measurement of Cholestrol: A Patient
Perspective. Circulation; 110: 296-297
Bendel, A., Beaty, O., Bottom, K., Bunin, G., Wrensch, M. 2006. Central
Nervous System Cancer. In : Bleyer, A., Leary, M., Barr, R., Ries,
L.A.G. editors. Cancer Epidemiology in Older Adoslescents and Young
Adults 15 to 29 Years of Age. National Cancer Institute. Bethesda.
Bondy, M.L., Scheurer, M.E., Malmer, B., Sloan, J.S.B., Davis, F.G.,
Ilyasova, D., dkk. 2008. Brain Tumor Epidemiology : Consensus from
the Brain Tumor Epidemiology Consortium. Cancer ; 113(7): 1953-1968
Brouwser, H.B, Goldstein, J.N. 2012 Therapeutic Strategies in Acute
Intracerebral Hemorrhage. Neurotherapeutics; 9: 87-98
Brunzell, J.D., Davidson, M., Furberg, C.D., Goldberg, R.B., Howard, B.V.,
Stein, J.H., dkk. 2008. Lipoprotein Management in Patients With
Cardiometabolic Risk. Diabetes Care; 31(4): 811-22
Caplan, L.R. 2000. Caplan’s Stroke : A Clinical Approach. 3rd
Butterworth-Heinemann. Boston
ed.
Cobbold, C.A., Sherratt, J.A., Maxwell, R.J. 2002. Lipoprotein Oxidation and
its Significance for Aterosclerosis : a Mathematical Approach. Bulletin of
Mathematical Biology; 64: 65-95
Crook, M.A. 2012. Plasma Lipids and Lipoproteins. In: Arnold, H., editors.
Clinical Biochemistry and Metabolic Medicine. Hodder Education. Pp.
200-207
Curb, J.D., Abbott, R.D., Rodriguez, B.L., dkk. 2004. High Density
Lipoprotein Cholestrol and the Risk of Stroke in Elderly Men. Am J
Epidemiol; 160(2): 150-7
Universitas Sumatera Utara
Dabrowa, A.B., Hannam, S., Rysz, J., Banach, M. 2011. MalignancyAssociated Dyslipidemia. The Open Cardiovascular Medicine Journal;
5: 35-40
Flaherty, M., Woo, D., Brodrick, J. 2010. The Epidemiology of Intracerebral
Hemorrhage. In: Carhuapoma, J.R, Mayer, S.A, Hanley, D.F., editors.
Intracerebral Hemorrhage. Cambridge University Press
Garcia, S.G., Concepcion, O.S., Carriera, R.F., Sainz, C.M., Maza, J.,
Monteagudo, A.G.Q., dkk. 2008. Association between Blood Lipids and
Types of Stroke. MEDICC Review; 10(2): 27-32
Gatchev, O., Rastam, L., Lindberg, G., Gullberg, B., Tornberg, S., Eklund,
G.A. 1994. Tumours of the Central Nervous System and Concentration
of Total Serum Cholestrol and β-Lipoprotein in Men and Women. Br J
Cancer; 70: 668-71
Growder, D., Riley, C., Morrison, E.Y., Gordon, L. 2011. The Role of HighDensity Lipoproteins in Reducing the Risk of Vascular Disease,
Neurodegenerative Disorders, and Cancer. Cholestrol; 2011 :1-9
Hasan, H.R., Al-Samaraae, S.S. 2009. Study of Lipoproteins in Patients with
Brain Tumor. Basic Sciences; 25(2): 9-18
Hu, J., Vecchia, L., Groh, M., Negri, E., Morrison, H., Mery, L. 2011. Dietary
Cholestrol Intake and Cancer. Annals of Oncloogy; 23(2): 491-500
Hill, C.I., Nixon, C.S., Ruehmeier, J.L., Wolf, L.M. 2002. Brain Tumours. Phys
Ther;82: 496-502
Jonas, A. 2002. Lipoprotein Structure. In : Vance, D.E., Vance, J.E., editors.
Lipoprotein and Membranes. Elsvier Science B.V. Pp.483-504
Konsensus Pengelolaan dan Pencegahan Diabetes Melitus Tipe 2 di
Indonesia. Jakarta. 2006.
Langsted, A., Freiberg, J.J., Nordestgaard, B.G. 2008. Influence of Normal
Fod Intake on Lipids, Lipoproteins, Apolipoproteins, and Cardiovascular
Risk Prediction. Circulation 118: 2047-56
Lloyd-Jones, D., Adams, R., Carnethon, M., Simone, G., Ferguson, B.,
Flegal, K. 2009. Heart Disease and Stroke Statistics-2009 Update : A
Report From the American Heart Association Statistics Committee and
Stroke Statistics Subcommittee. Circulation 119:e21-e181.
Universitas Sumatera Utara
Louis, D.N., Ohgaki, H., Wiestler, O.D., dkk. 2007. The 2007 WHO
Classification of Tumours of The Central Nervous System. Acta
Neuropathol; 114: 97-109
Machfoed, M.H. 2003. The Latest Clinical Epidemiological Data of Ischemic
and Hemorrhagic Stroke Patients in Surabaya and Surroundings. A
Hospital Based Study. Folia Medica Indonesia. 39:242-50
Mahmood, A., Sharif, M.A., Khan, M.N., Ali, U.Z. 2010. Comparison of Serum
Lipid Profile in Ischaemic and Haemorrhagic Stroke. Journal of the
College of Physicians and Surgeons Pakistan; 20(5): 317-20
McKinney, P.A. 2004. Brain Tumors: Incidence, Survival, and Aetiology. J
Neurol Neurosurg Psychiatry; 75: 12-17
Misbach, J. 2007. Pandangan Umum Mengenai Stroke. Dalam : Rasyid, A.
dan Soertidewi, L. (eds). Unit Stroke. Manajemen Stroke Secara
Komprehensif. Hal 1-9. Balai Penerbit FK Universitas Indonesia,
Jakarta.
Misbach, J. 2011. Stroke : Aspek Diagnostik, Patofisiologi, Manajemen.
Badan Penerbit FKUI.
Nigam, P.K. 2011. Serum Lipid Profile: Fasting or Non-fasting?. Ind J Clin
Biochem. 26(1) : 96-97
Oemiati, R., Rahajeng, E., Kristanto, A.Y. 2011. Prevalensi Tumor dan
Beberapa Faktor yang Mempengaruhinya di Indonesia. Buletin
Penelitian Kesehatan; 39: 190-204
Rader, D.J., Hobbs, H.H. 2010. Disorder of Lipoprotein Metabolism. In :
Jameson, J.L., editors. Endocrrinology. McGraw Hill Professional
Publishing. Pp 333-353
Rahmathulla, G., Toms, S.A., Weil, R.J. 2012. The Molecular Biology of Brain
Metastasis. Journal of Oncology; 2012 :1-13
Rodriguez, D., Rubiera, M., Ribo, M., dkk. 2011. Serum Low Density
Lipoprotein Cholestrol Level Predicts Hematoma Growth and Clinical
Outcome After Intracerebral Hemorrhage. Stroke; 42: 2447-52
Sacco, R.L., Kasner, S.E., Broderick, J.P., Caplan, L.R.,Culebras, A., Elkind,
M.S.V.,et al. 2013. An Update Defenition of Stroke for the 21st Century:
a Statement for Healthcare Professionals from the American Heart
Association/American Stroke Association. Stroke; 44:2064-2089
Universitas Sumatera Utara
Sjahrir, H. 2003. Stroke Iskemik. Yandira Agung Medan.
Soyama, Y., Miura, K., Morikawa, Y., Nishijo, M., Nakanishi, Y., Naruse, Y.,
dkk. 2003. High Density Lipoprotein Cholestrol and Risk of Stroke in
Japanese Men and Women : The Oyabe Study; 34: 863-8
Sredhar, K., Srikant, B., Joshi, L., Usha, G. 2010. Lipid Profile in NonDiabetic Stroke-A study of 100 Cases. JAPI; 58: 547-51
Truelsen, T., Piechonski-Jozwiak, B., Bonita, R. 2006. Stroke Incidence and
Prevalence in Europe: a review of available data. European Journal of
Neurology. 13(6):581-589
Wilhelm, I., Molnar, J., Fazakas, C., Hasko, J., Krizbai, I.A. 2013. Role of the
Blood-Brain Barrier in the Formation of Brain Metastases. Int. J. Mol.
Sci; 14: 1383-1411
Woodward, M., Barzi, F., Feigin, V., Gu, D., Huxley, R., Nakamura, K., et al.
2007. Associations between High-Density Lipoprotein Cholestrol and
both Stroke and Coronary Heart Disease in the Asia Pacific Region.
European Heart Journal; 28: 2653-2660
Universitas Sumatera Utara